Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma
Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundImmune checkpoint inhibitors (ICIs) have transformed treatment for melanoma, but identifying reliable biomarkers of response and effective modifiable lifestyle factors has been challenging. Obesity has been correlated with improved responses to ICI, although the association of body composition measures (muscle, fat, etc) with outcomes rem...
Alternative Titles
Full title
Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6dbe377bca014a8e9c17dfb7bb086289
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6dbe377bca014a8e9c17dfb7bb086289
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2020-000821
